•A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving durvalumab in combination with tremelimumab
•Opportunities and challenges harnessing antigen-specific CD4+ regulatory T cells in inflammatory bowel disease
•Passive smoking exposure and incidence and disease outcomes of inflammatory bowel disease: a systematic review and meta-analysis
•Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study
•Mesalamine-Induced Eosinophilic Pneumonia